Senseonics Holdings (SENS) Receives a Rating Update from a Top Analyst
In a report released yesterday, Marie Thibault from BTIG maintained a Hold rating on Senseonics Holdings (SENS). The company’s shares closed last Thursday at $2.69.
According to TipRanks.com, Thibault is a top 100 analyst with an average return of 93.9% and a 69.8% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Varian Medical Systems, and Edwards Lifesciences.
Senseonics Holdings has an analyst consensus of Hold, with a price target consensus of $0.85.
See today’s analyst top recommended stocks >>
Based on Senseonics Holdings’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $767K and GAAP net loss of $23.43 million. In comparison, last year the company earned revenue of $4.32 million and had a GAAP net loss of $19.5 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.